MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zeng, Yan ^a   Zhang, Xiaoying ^a   Kang, Kang ^b   Chen, Jidong ^a   Wu, Zhiqin ^a   Huang, Jinyong ^a   Lu, Wenju ^c   Chen, Yuqin ^c   Zhang, Jie ^c   Wang, Zhiwei ^d   Zhai, Yujia ^d   Qu, Junle ^a   Ramchandran, Ramaswamy ^e   Usha Raj, J ^e   Wang, Jian ^c,f   Gou, Deming ^a  

^a SHENZHEN UNIVERSITY   (China)

^b Shenzhen University School of Medicine   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d Shenzhen Sun Yat Sen Cardiovascular Hospital   (China)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC MYOSIN; MICRORNA; MIRN223 MICRORNA, HUMAN; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 2; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL; CELL CULTURE; HUMAN; HYPOXIA; METABOLISM; MOUSE; PHYSIOLOGY; RAT; SMOOTH MUSCLE CELL; VASCULAR REMODELING;

ANIMALS; CARDIAC MYOSINS; CELLS, CULTURED; HUMANS; HYPOXIA; MICE; MICRORNAS; MYOCYTES, SMOOTH MUSCLE; MYOSIN LIGHT CHAINS; RATS; RHOB GTP-BINDING PROTEIN; VASCULAR REMODELING;

EID: 84964914632     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24900     Document Type: Article

References (56)

1. Archer, S. L., Weir, E. K. & Wilkins, M. R. Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation 121, 2045-66 (2010).
2. Humbert, M. et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43, 13S-24S (2004).
3. Crosswhite, P. & Sun, Z. Molecular mechanisms of pulmonary arterial remodeling. Mol Med 20, 191-201 (2014).
4. Heasman, S.J. & Ridley, A. J. Mammalian Rho GTPases: new insights into their functions fromm vivo studies. Nat Rev Mol Cell Biol 9, 690-701(2008).
5. Wojciak-Stothard, B. et al. Role of RhoB in the regulation of pulmonary endothelial and smooth muscle cell responses to hypoxia. Ore Res 110, 1423-34(2012).
6. Kajimoto, H. et al Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction. Circulation 115, 1777-88 (2007).
7. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-97 (2004).
8. Dang, L. T., Lawson, N. D. & Fish, J. E. MicroRNA control of vascular endothelial growth factor signaling output during vascular development. Arterioscler Thromb Vasc Biol 33, 193-200 (2013).
9. Davis, B. N., Hilyard, A. C, Lagna, G. & Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56-61(2008).
10. Sarkar, J. et al MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol 299, L861-71 (2010).
11. Courboulin, A. et al Role for miR-204in human pulmonary arterial hypertension. J Exp Med 208, 535-48 (2011).
12. Rangrez, A. Y., Massy, Z. A., Metzinger-Le Meuth, V. &Metzinger, L. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 4, 197-205 (2011).
13. Cordes, K. R. et al miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460, 705-10 (2009).
14. Kang, K. et al MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells. J Biol Chem 288, 25414-27 (2013).
15. Wang, D. et al MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ Res 114, 67-78 (2014).
16. Tang, H., Ayon, R. J. &Yuan, J.X. New insights into the pathology of pulmonary hypertension: implication of themiR-210/ISCUl/2/Fe-S axis. EMBO Mol Med 7, 689-91 (2015).
17. Chen, T. et al Loss of microRNA-17 approximately 92 in smooth muscle cells attenuates experimental pulmonary hypertension via induction of PDZ and LIM domain S. Am J Respir Crit Care Med 191, 678-92 (2015).
18. Brock, M. et al. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension. Eur Heart J 35, 3203-11 (2014).
19. Parikh, V. N. et al. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 125, 1520-32 (2012).
20. Lu, H., Buchan, R. J. & Cook, S. A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc fc 86, 410-20 (2010).
21. Sun, W et al. miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LM02 isoforms and CEBP-beta. Cell Res 20, 1158-69 (2010).
22. Eyholzer, M. et al. Complexity of miR-223 regulation by CEBPA in human AML. Leuk Res 34, 672-6 (2010).
23. Wong, Q. W. et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathminl. Gastroenterology 135, 257-69 (2008).
24. Laios, A. et al. Potential role of miR-9 andmiR-223 in recurrent ovarian cancer. Mol Cancer 7, 35 (2008).
25. Harraz, M. M., Eacker, S. M., Wang, X., Dawson, T. M. & Dawson, V. L. MicroRNA-223 is neuroprotective by targeting glutamate receptors. Proc Natl Acad Sci USA 109, 18962-7 (2012).
26. Greco, S. et al Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J23, 3335-46 (2009).
27. Shi, L. et al MicroRNA-223 antagonizes angiogenesis by targeting betal integrin and preventing growth factor signaling in endothelial cells. Circ Res 113, 1320-30(2013).
28. Pietra, G. G. et al Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43, 25S-32S (2004).
29. Chen, B., Calvert, A. E., Cui, H. & Nelin, L. D. Hypoxia promotes human pulmonary artery smooth muscle cell proliferation through induction of arginase. Am J Physiol Lung Cell Mol Physiol 297, L1151-9 (2009).
30. Totsukawa, G. et al Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J. Cell Biol 150, 797-806 (2000).
31. Singh, D. K., Sarkar, J., Raghavan, A., Reddy, S. P. & Raj, J. U. Hypoxia modulates the expression of leucine zipper-positive MYPTl and its interaction with protein kinase G and Rho kinases in pulmonary arterial smooth muscle cells. Pulm Circ 1, 487-98 (2011).
32. Di Stefano, V., Zaccagnini, G., Capogrossi, M. C. &Martelli, F. microRNAs as peripheral blood biomarkers of cardiovascular disease. Vascul Pharmacol 55, 111-8 (2011).
33. Wang, G. K. et al Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J31, 659-66 (2010).
34. Wei, C. et al Circulating miRNAs as potential marker for pulmonary hypertension. PLos One 8, e64396 (2013).
35. Evans, A. M., Hardie, D. G., Peers, C. & Mahmoud, A. Hypoxic pulmonary vasoconstriction: mechanisms of oxygen-sen sing. Curr Opin Anaesthesiol24, 13-20 (2011).
36. Hale, A. E., White, K. & Chan, S. Y. Hypoxamirs in Pulmonary Hypertension: Breathing New Life into Pulmonary Vascular Research. Cardiovasc Diagn Ther 2, 200-212 (2012).
37. Caruso, P. et al Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia andmonocrotaline. Arten'osder Thromb Vase Biol 30, 716-23 (2010).
38. Rangrez, A. Y. et al. Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223. PLos One 7, e47807 (2012).
39. Meloche, J. et al. Role for DNA damage signaling in pulmonary arterial hypertension. Circulation 129, 786-97 (2014).
40. Meloche, J. et al. MiR-223 Reverses Experimental Pulmonary Arterial Hypertension. Am J Physiol Cell Physiol, ajpcell 00149 2015 (2015).
41. fmR. Nucleic Acids Res 38, 239-52 (2010).
42. Raman, N. & Atkinson, S. J. Rho controls actin cytoskeletal assembly in renal epithelial cells during ATP depletion and recovery. Am J Physiol 276, C1312-24 (1999).
43. Lu, Q., Longo, E M., Zhou, H., Massa, S. M. & Chen, Y H. Signaling through Rho GTPase pathway as viable drug target. Curr Med Chem 16, 1355-65 (2009).
44. Ji, X. et al. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55, 1944-9 (2009).
45. Tanaka, M. et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLos One 4, e5532 (2009).
46. Chen, X., Liang, H., Zhang, J., Zen, K. & Zhang, C. Y Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol22, 125-32(2012).
47. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105, 10513-8(2008).
48. Zampetaki, A. et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107, 810-7 (2010).
49. Zampetaki, A. et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 60, 290-9 (2012).
50. Zhang, Y Y et al. Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. J. Thromb Thrombolysis 38, 65-72 (2013).
51. de Torres, J. P. et al. Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study. PLos One 6, e 16021 (2011).
52. Ma, K. et al. Human lung microRNA profiling in pulmonary arterial hypertension secondary to congenital heart defect. Pediatr Pulmonol 80, 1214-23 (2015).
53. Kang, K. et al. A novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity. PLoS One 7, e48536 (2012).
54. Niu, Y et al. An improved method for detecting circulating microRNAs with S-Poly(T) Plus real-time PCR. Sci Rep 5, 15100 (2015).
55. Gou, D. et al. miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia. Am J Physiol Lung Cell Mol Physiol 303, 1682-91 (2012).
56. Shimoda, L. A. & Semenza, G. L. Functional analysis of the role of hypoxia-inducible factor 1 in the pathogenesis of hypoxic pulmonary hypertension. Methods Enzymol 381, 121-9 (2004).